Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study.

@article{Pottegrd2013UseOB,
  title={Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study.},
  author={A. Potteg{\aa}rd and S. Friis and M. Andersen and J. Hallas},
  journal={British journal of clinical pharmacology},
  year={2013},
  volume={75 5},
  pages={
          1356-64
        }
}
  • A. Pottegård, S. Friis, +1 author J. Hallas
  • Published 2013
  • Medicine
  • British journal of clinical pharmacology
  • AIM Studies of the carcinogenic potential of benzodiazepines and related drugs (BZRD) have been equivocal. A recent study reported a 35% excess cancer risk among users of hypnotics, including benzodiazepines. METHOD Using Danish nationwide registers, we conducted a matched case-control study of the association between BZRD and cancer risk. During 1 January 2002 and 31 December 2009, we identified 152 510 cases with a first time cancer who were matched (1:8) by age and gender to 1,220,317… CONTINUE READING
    36 Citations
    Is Long-term Use of Benzodiazepine a Risk for Cancer?
    • 28
    Do all hypnotic and sedatives have risk for cancer?
    • 6
    Hypnotics and Risk of Cancer: A Meta-Analysis of Observational Studies
    • PDF

    References

    SHOWING 1-10 OF 41 REFERENCES
    Benzodiazepines and risk for breast cancer.
    • 17
    Diazepam use in relation to breast cancer: results from two case-control studies.
    • 11
    Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Health and Aging.
    • 87